Excellent Formulations Private Limited
About Excellent Formulations Private Limited
Data last updated:
Excellent Formulations Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 February 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52311DL2015PTC276484.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Arshad Ali and Shoyab Ali.
Its last annual general meeting (AGM) was held on 15 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No 4B Kh. No. 11/11 & 11/20 Qutub Vihar Phase – 1 Main Jhankar Road, New Delhi, Delhi, India – 110071.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.57 Cr, a growth of 86% compared to the previous year. For the same year it recorded a net profit of ₹2.49 Lakh (net margin 0.7%) and EBITDA of ₹3.52 Lakh (EBITDA margin 1%).
Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Excellent Formulations Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressNo 4B Kh. No. 11/11 & 11/20 Qutub Vihar Phase – 1 Main Jhankar Road, New Delhi, Delhi, India – 110071
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Excellent Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Excellent Formulations is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Excellent Formulations Private Limited, buy the company report.
Financials of Excellent Formulations Private Limited
FY 2025 filings availableExcellent Formulations Private Limited reported revenue of ₹3.57 Cr (up 86% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 86% in the latest year. EBITDA rose 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.52 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.49 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Excellent Formulations Private Limited, buy the company report.
Board of directors of Excellent Formulations Private Limited
Excellent Formulations has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arshad Ali Also directs: Landway Buildcon LLP | Director | 02 May 2019 | 7 Years 5 Months | Current |
| Shoyab Ali | Director | 02 May 2019 | 7 Years 5 Months | Current |
| Nisha Ali | Director | 02 May 2019 | 7 Years 5 Months | Current |
Auditor
Excellent Formulations Private Limited is audited by HARESH MISHRA & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HARESH MISHRA & ASSOCIATES | FY 2018 | 024716N |
Shareholding
The shareholding of Excellent Formulations Private Limited is on record for 2 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Excellent Formulations Private Limited, buy the company report.
Legal cases
Excellent Formulations Private Limited has 1 court case on record: 1 filed by Excellent Formulations. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Principal Bench | Appeal | Filed by the company against Registrar of Companies NCT of Delhi & Haryana and 1 other | Disposed |
To see the full case history of Excellent Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Excellent Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Excellent Formulations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Excellent Formulations Private Limited has 9 board changes on record since 2019: 3 appointments and 6 cessations. The latest: Anandam Sinha ceased to be Director on 07 May 2019.
Frequently asked questions
Excellent Formulations is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 February 2015 (11+ years old) and is registered under CIN U52311DL2015PTC276484.
Excellent Formulations has 3 current directors:
- Arshad Ali - Director
- Shoyab Ali - Director
- Nisha Ali - Director
The latest financial statements of Excellent Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 15 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Excellent Formulations is U52311DL2015PTC276484. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Excellent Formulations has 1 court case on record: 1 filed by the company.
Excellent Formulations was incorporated on 09 February 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Anandam Sinha ceased to be Director on 07 May 2019. Rajeev Sinha Kumar ceased to be Director on 07 May 2019. Arshad Ali was appointed as Director on 02 May 2019. Excellent Formulations has 9 board changes on record in total.
The registered office of Excellent Formulations is at No 4B Kh. No. 1111 & 1120 Qutub Vihar Phase – 1 Main Jhankar Road, New Delhi, Delhi, India – 110071.
Excellent Formulations operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Excellent Formulations is compliant as of 16 July 2026. The company is actively filing with the Registrar of Companies.